Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Bioinspired Polymer Nanoparticles Omit Biophysical Interactions with Natural Lung Surfactant.

Beck-Broichsitter M, Bohr A.

Nanotoxicology. 2019 May 21:1-29. doi: 10.1080/17435390.2019.1621400. [Epub ahead of print]

PMID:
31109226
2.

Exploring the potential for rosacea therapeutics of siRNA dispersion in topical emulsions.

Colombo S, Harmankaya N, Water JJ, Bohr A.

Exp Dermatol. 2019 Mar;28(3):261-269. doi: 10.1111/exd.13881. Epub 2019 Feb 12.

PMID:
30650201
3.

Efflux Inhibitor Bicalutamide Increases Oral Bioavailability of the Poorly Soluble Efflux Substrate Docetaxel in Co-Amorphous Anti-Cancer Combination Therapy.

Bohr A, Nascimento TL, Harmankaya N, Weisser JJ, Wang Y, Grohganz H, Rades T, Löbmann K.

Molecules. 2019 Jan 11;24(2). pii: E266. doi: 10.3390/molecules24020266.

4.

Molecular structure and impact of amorphization strategies on intrinsic dissolution of spray dried indomethacin.

Li Y, Rantanen J, Yang M, Bohr A.

Eur J Pharm Sci. 2019 Mar 1;129:1-9. doi: 10.1016/j.ejps.2018.12.010. Epub 2018 Dec 13.

PMID:
30553059
5.

Microfluidics-based self-assembly of peptide-loaded microgels: Effect of three dimensional (3D) printed micromixer design.

Borro BC, Bohr A, Bucciarelli S, Boetker JP, Foged C, Rantanen J, Malmsten M.

J Colloid Interface Sci. 2019 Mar 7;538:559-568. doi: 10.1016/j.jcis.2018.12.010. Epub 2018 Dec 4.

PMID:
30551068
6.

Whey proteins as stabilizers in amorphous solid dispersions.

Mishra J, Bohr A, Rades T, Grohganz H, Löbmann K.

Eur J Pharm Sci. 2019 Feb 1;128:144-151. doi: 10.1016/j.ejps.2018.12.002. Epub 2018 Dec 4.

PMID:
30528387
7.

Poly(ethylene carbonate)-containing polylactic acid microparticles with rifampicin improve drug delivery to macrophages.

Priemel PA, Wang Y, Bohr A, Water JJ, Yang M, Mørck Nielsen H.

J Pharm Pharmacol. 2018 Aug;70(8):1009-1021. doi: 10.1111/jphp.12937. Epub 2018 May 30.

PMID:
29851078
8.

Transforming nanomedicine manufacturing toward Quality by Design and microfluidics.

Colombo S, Beck-Broichsitter M, Bøtker JP, Malmsten M, Rantanen J, Bohr A.

Adv Drug Deliv Rev. 2018 Mar 15;128:115-131. doi: 10.1016/j.addr.2018.04.004. Epub 2018 Apr 5. Review.

PMID:
29626549
9.

Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing.

Genina N, Boetker JP, Colombo S, Harmankaya N, Rantanen J, Bohr A.

J Control Release. 2017 Dec 28;268:40-48. doi: 10.1016/j.jconrel.2017.10.003. Epub 2017 Oct 6.

PMID:
28993169
10.

The effect of HPMC and MC as pore formers on the rheology of the implant microenvironment and the drug release in vitro.

Aho J, Halme A, Boetker J, Water JJ, Bohr A, Sandler N, Rantanen J, Baldursdottir S.

Carbohydr Polym. 2017 Dec 1;177:433-442. doi: 10.1016/j.carbpol.2017.08.135. Epub 2017 Sep 1.

PMID:
28962789
11.

Poloxamer-Decorated Polymer Nanoparticles for Lung Surfactant Compatibility.

Beck-Broichsitter M, Bohr A, Ruge CA.

Mol Pharm. 2017 Oct 2;14(10):3464-3472. doi: 10.1021/acs.molpharmaceut.7b00477. Epub 2017 Aug 30.

PMID:
28813610
12.

Inhalable siRNA-loaded nano-embedded microparticles engineered using microfluidics and spray drying.

Agnoletti M, Bohr A, Thanki K, Wan F, Zeng X, Boetker JP, Yang M, Foged C.

Eur J Pharm Biopharm. 2017 Nov;120:9-21. doi: 10.1016/j.ejpb.2017.08.001. Epub 2017 Aug 2.

PMID:
28780275
13.

The Microbiome in Posttraumatic Stress Disorder and Trauma-Exposed Controls: An Exploratory Study.

Hemmings SMJ, Malan-Müller S, van den Heuvel LL, Demmitt BA, Stanislawski MA, Smith DG, Bohr AD, Stamper CE, Hyde ER, Morton JT, Marotz CA, Siebler PH, Braspenning M, Van Criekinge W, Hoisington AJ, Brenner LA, Postolache TT, McQueen MB, Krauter KS, Knight R, Seedat S, Lowry CA.

Psychosom Med. 2017 Oct;79(8):936-946. doi: 10.1097/PSY.0000000000000512.

14.

Anti-Inflammatory Effect of Anti-TNF-α SiRNA Cationic Phosphorus Dendrimer Nanocomplexes Administered Intranasally in a Murine Acute Lung Injury Model.

Bohr A, Tsapis N, Andreana I, Chamarat A, Foged C, Delomenie C, Noiray M, El Brahmi N, Majoral JP, Mignani S, Fattal E.

Biomacromolecules. 2017 Aug 14;18(8):2379-2388. doi: 10.1021/acs.biomac.7b00572. Epub 2017 Jul 5.

PMID:
28639789
15.

Impact of triblock copolymers on the biophysical function of naturally-derived lung surfactant.

Beck-Broichsitter M, Ruge CA, Bohr A.

Colloids Surf B Biointerfaces. 2017 Aug 1;156:262-269. doi: 10.1016/j.colsurfb.2017.05.044. Epub 2017 May 17.

PMID:
28544958
16.

Investigation of nanocarriers and excipients for preparation of nanoembedded microparticles.

Wang Y, Beck-Broichsitter M, Yang M, Rantanen J, Bohr A.

Int J Pharm. 2017 Jun 30;526(1-2):300-308. doi: 10.1016/j.ijpharm.2017.05.008. Epub 2017 May 4.

PMID:
28479517
17.

Molecular weight-dependent degradation and drug release of surface-eroding poly(ethylene carbonate).

Bohr A, Wang Y, Harmankaya N, Water JJ, Baldursdottír S, Almdal K, Beck-Broichsitter M.

Eur J Pharm Biopharm. 2017 Jun;115:140-148. doi: 10.1016/j.ejpb.2017.02.011. Epub 2017 Feb 24.

PMID:
28238837
18.

Chitosan-Based Nano-Embedded Microparticles: Impact of Nanogel Composition on Physicochemical Properties.

Islam P, Water JJ, Bohr A, Rantanen J.

Pharmaceutics. 2016 Dec 22;9(1). pii: E1. doi: 10.3390/pharmaceutics9010001.

19.

High-Throughput Fabrication of Nanocomplexes Using 3D-Printed Micromixers.

Bohr A, Boetker J, Wang Y, Jensen H, Rantanen J, Beck-Broichsitter M.

J Pharm Sci. 2017 Mar;106(3):835-842. doi: 10.1016/j.xphs.2016.10.027. Epub 2016 Dec 6.

PMID:
27938892
20.

Potential of surface-eroding poly(ethylene carbonate) for drug delivery to macrophages.

Bohr A, Water JJ, Wang Y, Arnfast L, Beck-Broichsitter M.

Int J Pharm. 2016 Sep 25;511(2):814-20. doi: 10.1016/j.ijpharm.2016.07.075. Epub 2016 Aug 1.

PMID:
27492019

Supplemental Content

Loading ...
Support Center